Navigation Links
High-Fidelity PCR with a Novel Polymerase Mixture

figure 1

As with many commercially available two-polymerase mixtures, a potential limitation of the TaqPlus Long PCR system is its relatively low fidelity compared to Pfu DNA polymerase (figure 1). The TaqPlus Long PCR system exhibits an error rate similar to Taq DNA polymerase, the predominant component in the TaqPlus Long polymerase mixture. To address the needs of researchers requiring both high yields of PCR product and high replication fidelity, Stratagene has added the TaqPlus Precison PCR system to its expanding line of PCR products.

TaqPlus Long PCR System for Highest Yield and Long Targets

Certain mixtures of proofreading and nonproofreading DNA polymerases have been shown to significantly increase PCR product yield and enhance amplification of longer targets compared to single-enzyme formulations.16-18 The enhanced performance of polymerase mixtures is presumably due to the capacity of one enzyme to complement the inability of a second enzyme to extend a primer through potential template obstructions. These potential obstructions include mispaired bases that cause nonproofreading polymerases to stall prematurely and disassociate from the primer-template,16 abasic gaps that cannot be bridged by polymerases lacking terminal transferase activity19 and template secondary structures20 such as GC-rich hairpins.

The TaqPlus Long PCR system was developed for PCR amplifications of long DNA target regions (up to 35 kb) using relatively short extension times (0.5-1 minute per kb target). The system includes the TaqPlus Long DNA polymerase mixture, consisting of Taq2000 DNA polymerase and cloned Pfu DNA polymerases, and two reaction buffers. The low-salt buffer is recom
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
2. pfuturbo DNA Polymerase: A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning
3. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
4. Challenge the Performance of Your Hot-Start PCRs with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System
5. Combine High Yield, Great Accuracy and the Prevention of Carry-over Contamination by Using the Novel Expand High FidelityPLUS PCR System
6. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
7. A Novel Process for Gene Expression Profiling of Rat and Mouse Tissues from Formalin-Fixed Paraffin-Embedded Sections Using Microarrays
8. Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors
9. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
10. Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns
11. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High Fidelity PCR with Novel Polymerase Mixture

(Date:5/5/2015)... , May 05, 2015 Research ... has announced the addition of the ... to their offering. Macromolecules which ... undergo separation or are broken into smaller ... products. This separation requires various advanced systems ...
(Date:5/5/2015)... DIEGO , May 5, 2015  Renova™ ... for congestive heart failure and other chronic diseases, ... an independent analysis designed to reflect the healthcare ... time. This model will be used to characterize ... CHF, could have on those groups of patients ...
(Date:5/5/2015)... D.C., USA (PRWEB) May 05, 2015 ... regulations covering a wide range of key photonics technologies ... hampering global competitiveness of U.S. industry. To help the ... webinar on 12 May on the proposed changes ... the commodities covered by International Traffic in Arms Regulations ...
(Date:5/5/2015)... FRANCISCO, Calif. , May 5, 2015 ... treatment of cancer, today announced that Sean McCarthy ... the Credit Suisse Antibody Day in New ... May 6. Dr. McCarthy will present an overview of ... and Probody drug conjugate programs. About CytomX ...
Breaking Biology Technology:Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4
... 8 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... and live webcast at 9:00 a.m. Eastern Time on ... financial results.,Michael T. Flavin, Ph.D., Chairman & Chief Executive ... present an update on the Company.,A press release reporting ...
... Calif., Nov. 7 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products Group Corporation ... nine months of 2007 were $6,214,712,an increase of 567% ... Revenues for the third quarter of 2007 were ... third quarter of 2006. These significant,increases are due to ...
... at 1:30 p.m. (Pacific); ... http://www.adventrx.com , SAN DIEGO, Nov. 7 ... and development company,focused on commercializing proprietary product candidates for ... results for,the three-month and nine-month periods ended September 30, ...
Cached Biology Technology:Advanced Life Sciences to Host Third Quarter 2007 Financial Results Conference Call and Live Webcast 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 2Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 3Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 4Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 5Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 6Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 7Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 8Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million 9ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 2ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 3ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 4ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 5ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 6ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results 7
(Date:4/9/2015)... April 9, 2015 Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 2015, after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
(Date:4/2/2015)... April 2, 2015 According to ... attributed to somewhat higher than 125 MSEK. This exceeds ... report 2014 that revenues for Q1 2015 would be ... reported for Q4 2014. The operating result for the ... The complete interim report will as previously communicated be ...
(Date:3/31/2015)... 2015   Guidepoint , a leading global research ... Pain Management TRACKER, part of the Guidepoint TRACKER ... the medical device and therapeutics markets. The Post-Surgical Pain ... volumes, market share, and adoption rates across three major ... surgery. The Post-Surgical Pain Management TRACKER will ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... NYU Langone Medical Center,s Departments of Orthopaedic Surgery and ... to detect subtle changes in joint cartilage microstructure ... markers of early osteoarthritis (OA). By using these techniques ... shift the management of the disease from eventual joint ...
... The last century has seen two major pandemics caused ... and 2009,s Swine Flu scare, which had thousands travelling with ... know what distinguished the Swine Flu from ordinary influenza in ... to travel extensively and infect large populations. Until now. ...
... MO, August 15, 2011A compound found in green tea ... treat two types of tumors and a deadly congenital ... led by Principal Investigator, Dr. Thomas Smith at The ... The Children,s Hospital of Philadelphia. Their findings are published ...
Cached Biology News:NYU Langone experts find MRI techniques can detect early osteoarthritis 2Could the Spanish flu devastate us again? 2Researchers demonstrate green tea is effective in treating genetic disorder and types of tumors 2
Polyclonal Antibody to AGAP1 / Centaurin, gamma 2...
Mouse monoclonal [b/e4 (9.20)] to Cytochrome P450 2B1 + 2B2 ( Abpromise for all tested applications)....
Goat polyclonal to MLH3 Immunogen: Synthetic peptide: RQSLQQSMPPCEPP (Human) from C Terminus of the protein sequence according to NP_055196....
Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....
Biology Products: